News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
1–9
Matches
9
Sources here
4
Companies here
1
Search results Stored financial headlines

Active search

9 matching headlines

Ticker or company: MRCKMain company stories
Clear
Latest

finance.yahoo.com Guidance

Merck KGaA (MKGAF) (Q2 2026) Earnings Call Highlights: Robust Growth and Raised Guidance Signal ...

This article first appeared on GuruFocus. Net Sales: Increased from EUR5,255 million in Q2 2025 to EUR5,434 million in Q2 2026, with organic sales growth of 4.1%. EBITDA pre: Increased from EUR1.46 billion to EUR1.6 billion, with organic growth of 9.3% and reported growth of 9.4%. EBITDA pre Margin: Expanded by 1.6 percentage points year-over-year to 29.4%. EPS …

Evinova Launches Strategic Partnership with Merck KGaA, Darmstadt, Germany to Define the Future of Clinical Development

Evinova's full Study Designer with AI suite will be leveraged by Merck KGaA, Darmstadt, Germany to shape future product innovations and accelerate industry-wide transformation BAAR, Switzerland, July 29, 2026--(BUSINESS WIRE)--Evinova, a global leader in AI-native clinical development technology, today announced a new multi-year strategic …

MRCK main company
Sharemaestro market context Trend signal active 52 weeks +24.2% MRCK stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Merck KGaA (MKKGY) Moves to Strong Buy: Rationale Behind the Upgrade

Merck KGaA (MKKGY) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices. The Zacks …

MRCK main company
Sharemaestro market context Trend signal active 52 weeks +24.2% MRCK stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Should Value Investors Buy Merck KGaA (MKKGY) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. Of these, perhaps …

MRCK main company
Sharemaestro market context Trend signal active 52 weeks +24.2% MRCK stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Merck KGaA (XTRA:MRK) Opens New Darmstadt Testing Site As Pipeline Progress Builds

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Merck KGaA's MilliporeSigma unit has opened a new BioReliance testing facility in Darmstadt, Germany, expanding its biopharmaceutical testing footprint in Europe. The company reported a …

MRCK main company
Sharemaestro market context Trend signal active 52 weeks +24.2% MRCK stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context